{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:44:57Z","timestamp":1790891097199,"version":"4.1.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T00:00:00Z","timestamp":1576195200000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Maple syrup urine disease (MSUD) is a potentially life-threatening metabolic disorder caused by decreased activity of the branched-chain \u03b1-ketoacid dehydrogenase (BCKD) complex. Mutations in four genes (BCKDHA, BCKDHB, DLD and DBT) are associated with MSUD. Here, the presenting symptoms and clinical course of a case of MSUD with a novel DBT gene mutation are described.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We describe an infant with MSUD with the DBT gene mutation who had drowsiness and poor appetite as well as abnormal findings upon head magnetic resonance imaging (MRI), plasma amino acid analysis and urine organic acid analysis. Genetic testing revealed that both parents had the heterozygous mutation c.1132C\u2009&gt;\u2009T (p.378X) in chr1:100672078, and the patient had the homozygous mutations c.1132C\u2009&gt;\u2009T (p.378X) in chr1:100672078. Once diagnosed with MSUD, the patient\u2019s disease was controlled with a diet of BCAA-free enteral formula and thiamine.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The mutation c.1132C\u2009&gt;\u2009T (p.378X) is a novel DBT gene mutation that is associated with MSUD and always has mild clinical manifestations. After timely BCAA-free nutrition and supplementation with thiamine for the patient, the plasma levels of BCAAs reached a safe level, the abnormal range of the multiple intracranial abnormalities was significantly smaller than before, and the symptoms of drowsiness and poor appetite disappeared.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12887-019-1880-1","type":"journal-article","created":{"date-parts":[[2019,12,13]],"date-time":"2019-12-13T02:02:29Z","timestamp":1576202549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Case report: maple syrup urine disease with a novel DBT gene mutation"],"prefix":"10.1186","volume":"19","author":[{"given":"Wei","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyang","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,13]]},"reference":[{"issue":"5","key":"1880_CR1","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1542\/peds.14.5.462","volume":"14","author":"JH Menkes","year":"1954","unstructured":"Menkes JH, Hurst PL, Craig JM. A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance[J]. Pediatrics. 1954;14(5):462\u20137.","journal-title":"Pediatrics"},{"issue":"1","key":"1880_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11011-016-9867-1","volume":"32","author":"M Abiri","year":"2016","unstructured":"Abiri M, Karamzadeh R, Mojbafan M, et al. In silico analysis of novel mutations in maple syrup urine disease patients from Iran[J]. Metab Brain Dis. 2016;32(1):105\u201313. https:\/\/doi.org\/10.1007\/s11011-016-9867-1.","journal-title":"Metab Brain Dis"},{"key":"1880_CR3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/TACG.S125962","volume":"10","author":"R Blackburn Patrick","year":"2017","unstructured":"Blackburn Patrick R,Gass Jennifer M,Vairo Filippo Pinto E et al. # .Appl Clin Genet, 2017, 10: 57\u201366. doi: https:\/\/doi.org\/10.2147\/TACG.S125962.","journal-title":"Appl Clin Genet"},{"key":"1880_CR4","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1091\/mbc.11.5.1919","volume":"11","author":"P Jouvet","year":"2000","unstructured":"Jouvet P, Rustin P, Taylor DL, et al. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease [J]. Mol Biol Cell. 2000;11:1919\u201332. https:\/\/doi.org\/10.1091\/mbc.11.5.1919.","journal-title":"Mol Biol Cell"},{"issue":"1","key":"1880_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-014-0159-8","volume":"9","author":"NA Zeltner","year":"2014","unstructured":"Zeltner NA, Huemer M, Baumgartner MR, et al. Quality of life, psychological adjustment, and adaptive functioning of patients with intoxication-type inborn errors of metabolism-a systematic review[J]. Orphanet J Rare Dis. 2014;9(1):159. https:\/\/doi.org\/10.1186\/s13023-014-0159-8.","journal-title":"Orphanet J Rare Dis"},{"key":"1880_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","volume":"112","author":"M Frazier Dianne","year":"2014","unstructured":"Frazier Dianne M. Allgeier Courtney,Homer Caroline et al. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach.[J]. Mol Genet Metab. 2014;112:210\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2014.05.006.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"1880_CR7","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.ymgme.2014.05.006","volume":"112","author":"DM Frazier","year":"2014","unstructured":"Frazier DM, Allgeier C, Homer C, et al. Nutrition management guideline for maple syrup urine disease: an evidence- and consensus-based approach[J]. Mol Genet Metab. 2014;112(3):210\u20137. https:\/\/doi.org\/10.1016\/j.ymgme.2014.05.006.","journal-title":"Mol Genet Metab"},{"key":"1880_CR8","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1023\/a:1012767127434","volume":"24","author":"D Delis","year":"2001","unstructured":"Delis D, Michelakakis H, Katsarou E, Bartsocas CS. Thiamin-responsive maple syrup urine disease: seizures after 7 years of satisfactory metabolic control. J Inherit Metab Dis. 2001;24:683\u20134. https:\/\/doi.org\/10.1023\/a:1012767127434.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"1880_CR9","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1172\/JCI119586","volume":"100","author":"J L Chuang","year":"1997","unstructured":"Chuang JL, Cox RP, Chuang DT. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype, J. Clin Investig. 100(1997):736\u201344. https:\/\/doi.org\/10.1172\/JCI119586.","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"1880_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s11011-017-0168-0","volume":"33","author":"X Li","year":"2018","unstructured":"Li X, Yang Y, Gao Q, et al. Clinical characteristics and mutation analysis of five Chinese patients with maple syrup urine disease. Metab Brain Dis. 2018;33(3):741\u201351. https:\/\/doi.org\/10.1007\/s11011-017-0168-0.","journal-title":"Metab Brain Dis"},{"issue":"135","key":"1880_CR11","doi-asserted-by":"publisher","first-page":"1565S","DOI":"10.1093\/jn\/135.6.1565S","volume":"135","author":"H Mitsubuchi","year":"2005","unstructured":"Mitsubuchi H, Owada M, Endo F. Markers associated with inborn errors of metabolism of branched-chain amino acids and their relevance to upper levels of intake in healthy people: an implication from clinical and molecular investigations on maple syrup urine disease[J]. J Nutr. 2005;135(135):1565S\u201370S. https:\/\/doi.org\/10.1093\/jn\/135.6.1565S.","journal-title":"J Nutr"},{"issue":"10","key":"1880_CR12","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/clinchem\/45.10.1734","volume":"45","author":"P Schadewaldt","year":"1999","unstructured":"Schadewaldt P, Bodner-Leidecker A, Hammen HW, et al. Significance of L-alloisoleucine in plasma for diagnosis of maple syrup urine disease[J]. Clin Chem. 1999;45(10):1734.","journal-title":"Clin Chem"},{"issue":"1","key":"1880_CR13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s11064-007-9423-9","volume":"33","author":"C\u00e9sar A. Ribeiro","year":"2007","unstructured":"Ribeiro CA, Sgaravatti AM, Rosa RB, et al. Inhibition of brain energy metabolism by the branched-chain amino acids accumulating in maple syrup urine disease[J]. Neurochem Res, 2008, 33(1):114\u2013124. doi: https:\/\/doi.org\/10.1007\/s11064-007-9423-9.","journal-title":"Neurochemical Research"},{"issue":"5","key":"1880_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.5152\/dir.2017.16466","volume":"23","author":"C Ailan","year":"2017","unstructured":"Ailan C, Lianshu H, Yun F, et al. MRI and clinical features of maple syrup urine disease: preliminary results in 10 cases[J]. Diagn Interv Radiol. 2017;23(5):398\u2013402. https:\/\/doi.org\/10.5152\/dir.2017.16466.","journal-title":"Diagn Interv Radiol"},{"issue":"4","key":"1880_CR15","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1055\/s-0032-1332741","volume":"44","author":"D Terek","year":"2013","unstructured":"Terek D, Koroglu O, Yalaz M, et al. Diagnostic tools of early brain disturbances in an asymptomatic neonate with maple syrup urine disease[J]. Neuropediatrics. 2013;44(4):208\u201312. https:\/\/doi.org\/10.1055\/s-0032-1332741.","journal-title":"Neuropediatrics"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1880-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1880-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1880-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T10:39:15Z","timestamp":1665225555000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1880-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1880"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1880-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"24 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parent for the publication of this case report and any accompanying images.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"494"}}